PebbleAtlas
PEBBLE / ATLAS
Open research access
← Studies/PMID 26648661
PRECLINICAL PUBLICATION · 2015

3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.

Mouse / Endotoxin/LPS

Read on PubMed ↗Suggest a correction

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26648661 ↗2015Reported benefit

3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.

MouseEndotoxin/LPSMalePretreatmentBefore LPS

Model: Lipopolysaccharide-induced acute respiratory distress syndrome

Acetylated resveratrol reduced mortality and lung inflammation in LPS-induced ARDS via the p38 MAPK/SIRT1 pathway.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.